Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
144.90    2.60 (1.83%)
Bid:
145.30
Ask:
145.60
Spread: 0.30 (0.206%)
Market Cap: £366.44m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Holding(s) in Company

27 Nov 2008 14:55

RNS Number : 1016J
Marshalls PLC
27 November 2008
 



TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Marshalls plc

2. Reason for the notification (please tick the appropriate box or boxes)

An acquisition of voting rights 

X

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An event changing the breakdown of voting rights

Other (please specify): Transitional notification of holdings

3. Full name of person(s) subject to the notification obligation:

JP Morgan Chase & Co

4. Full name of shareholder(s) (if different from 3.):

JP Morgan Asset Management (UK) Limited

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

24 November 2008

6. Date on which issuer notified:

26 November 2008

7. Threshold(s) that is/are crossed or reached:

Above 5%

8. Notified details:

 

A: Voting rights attached to shares

Class/type of shares 

 if possible using the ISIN CODE

Situation previous to the Triggering transaction 

Resulting situation after the triggering transaction

Number of Shares 

Number of Voting Rights

Number of shares 

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB00B012BV22

N/A

N/A

7,299,301

5.19%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument 

Expiration date

Exercise/ Conversion Period/ Date 

Number of voting rights that may be acquired if the instrument is exercised/ converted

% of voting rights

N/A

N/A

N/A

N/A

N/A

Total (A+B)

Number of voting rights

% of voting rights

7,299,301

5.19%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

JP Morgan Chase & Co

JP Morgan Asset Management (UK) Limited

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

14. Contact name:

Cathy Baxandall, Company Secretary,

Marshalls plc

15. Contact telephone number:

01484 438900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLILFVSLALDFIT
Date   Source Headline
11th Dec 202411:27 amRNSHolding(s) in Company
10th Dec 202412:30 pmRNSDirector/PDMR Shareholding
10th Dec 202412:28 pmRNSDirector/PDMR Shareholding
10th Dec 202412:26 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSCapital Markets Event
14th Nov 202410:45 amRNSHolding(s) in Company
12th Nov 202412:02 pmRNSDirector/PDMR Shareholding
12th Nov 202411:47 amRNSDirector/PDMR Shareholding
12th Nov 202411:44 amRNSDirector/PDMR Shareholding
31st Oct 202411:18 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSQ3 Trading Update
15th Oct 20249:45 amRNSDirector/PDMR Shareholding
15th Oct 20249:43 amRNSDirector/PDMR Shareholding
15th Oct 20249:42 amRNSDirector/PDMR Shareholding
10th Sep 20244:59 pmRNSDirector/PDMR Shareholding
23rd Aug 20242:57 pmRNSDirector/PDMR Shareholding
16th Aug 202411:21 amRNSHolding(s) in Company
12th Aug 20247:00 amRNSHalf-year Report
25th Jul 20247:00 amRNSNotice of Interim Results
3rd Jun 20243:17 pmRNSDirector/PDMR Shareholding
15th May 20241:01 pmRNSResult of AGM
15th May 20247:00 amRNSTrading Statement
29th Apr 20243:25 pmRNSDirector/PDMR Shareholding - Correction
29th Apr 202411:45 amRNSDirector/PDMR Shareholding
19th Apr 20248:51 amRNSHolding(s) in Company
10th Apr 20242:03 pmRNSAnnual Financial Report
22nd Mar 202412:40 pmRNSDirector/PDMR Shareholding
19th Mar 20242:00 pmRNSDirector/PDMR Shareholding
19th Mar 20241:59 pmRNSDirector/PDMR Shareholding
19th Mar 20241:57 pmRNSDirector/PDMR Shareholding
19th Mar 20241:56 pmRNSDirector/PDMR Shareholding
18th Mar 202412:07 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFinal Results
26th Feb 202410:36 amRNSDirector/PDMR Shareholding
15th Feb 20249:49 amRNSHolding(s) in Company
1st Feb 202411:59 amRNSHolding(s) in Company
31st Jan 20241:17 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:36 amRNSHolding(s) in Company
6th Dec 20237:00 amRNSCEO Succession
1st Dec 20233:08 pmRNSHolding(s) in Company
28th Nov 20233:17 pmRNSHolding(s) in Company
7th Nov 20231:47 pmRNSStatement re 2023 AGM Remuneration Report Vote
3rd Nov 202310:38 amRNSDirector Declaration
27th Oct 20239:56 amRNSHolding(s) in Company
23rd Oct 20234:14 pmRNSHolding(s) in Company
20th Oct 202310:36 amRNSHolding(s) in Company
18th Oct 20234:04 pmRNSHolding(s) in Company
18th Oct 20234:02 pmRNSHolding(s) in Company
18th Oct 202312:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.